TWD
ANAB icon

True Wealth Design’s AnaptysBio ANAB Stock Holding History

True Wealth Design’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270 Hold
4
– – ﹤0.01% 2382
2026
Q1 		$222 Hold
4
– – ﹤0.01% 2312
2025
Q4 		$194 Hold
4
– – ﹤0.01% 2234
2025
Q3 		$123 Hold
4
– – ﹤0.01% 2411
2025
Q2 		$89 Sell
4
-63
-94% -$1.32K ﹤0.01% 2273
2025
Q1 		$1.25K Buy
+67
New +$1.12K ﹤0.01% 1188
2024
Q4 		– Sell
-15
Closed -$503 – 1356
2024
Q3 		$503 Buy
+15
New +$512 ﹤0.01% 1098

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

True Wealth Design's ANAB Position: Q2 2026 in Review

True Wealth Design held its AnaptysBio (ANAB) position steady in Q2 2026 at 4 shares worth $270. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

True Wealth Design first reported a position in ANAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.25K in Q1 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • True Wealth Design held 4 shares of AnaptysBio worth $270 as of Q2 2026.
  • True Wealth Design left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2382 holding.
  • True Wealth Design first reported a position in AnaptysBio in Q3 2024 and has held it in 7 quarters since.
  • True Wealth Design's AnaptysBio position peaked at $1.25K in Q1 2025.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.